A study published in Clinical Gastroenterology and Hepatology highlights findings from the first-ever in-human trial using a special real-time artificial intelligence system to diagnose cancer in the digestive system.
Led by Neil Marya, MD, assistant professor of medicine, director of the Program in Digital Medicine, and director of the Digital Medicine Fellowship at UMass Chan Medical School, the SMART-AI trial showed that using AI was better at diagnosing cholangiocarcinoma, or bile duct cancer, than a biopsy.